Generics 13

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Diclofenac sodium manufacturers

13 products found

Filters

Filters

Filters , active

Country of origin : South-korea

Clear all

13 products found

diclofenac sodium

Ampoules, injection 75mg/2ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #8104
It was established in the late 1950s. It has been making significant efforts to protect the healthy lives of human beings by producing a variety of treatments starting with injection Products. The company operates its business for various customers including business clients, patients, pharmacists, and doctors. They are trying to make their supply chain more effective to provide the necessary medicines faster.

Manufacturer usually replies in 4 days

diclofenac sodium

Ampoules, injection 37.5 mg/ml - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #17971
It was one of the leading manufacturers of infusion solutions. The company manufactured the first infusion as the basis of national health, opening a new horizon for medical companies and growing as a representative infusion manufacturer. They have procured over 200 types of finished medicines for treatment, and they are leading markets for therapeutic drugs and keeping patients healthy in diverse medical fields.

Manufacturer usually replies in 9 days

diclofenac sodium

Solution for injection 75 mg/2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

diclofenac sodium

Eye drops 1 mg/ml - 6 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #446
It was established in the late 1950s with one ideology of respect for life and customer first. One of the major achievements of the company is in the field of ophthalmic disease. All products are GMP certified. The manufacturer sells more than 150 prescription medicine which includes the circulatory and digestive system, as well as antibiotics. It is an international company that delivers pharmaceutical products to domestic and international markets in China, ASEAN countries, the Middle East, Africa, and more.

Manufacturer usually replies in 9 days

diclofenac sodium + lidocaine

Ampoules, injection 37.5 mg + 10 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18085
The company was formed in the 2010s. It concentrates on the biotech division. It provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry. It has more than 2 manufacturing plants. It is one of the world's largest contract-based manufacturers in the biopharmaceutical sector at a single site as of the 2010s.

Manufacturer usually replies in 14 days

diclofenac sodium

Tablets 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #17974
It was established in the 1890s. The company is committed to bringing happiness to customers and employees with its management focusing on the happiness of people. Based on respect for the shared value that "the company work diligently in the youths and live fruitful lives in old age." it serves every customer faithfully by fostering ownership and faith among its members.

Manufacturer usually replies in 13 days

diclofenac sodium

Ampoules, injection 75 mg / 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #17974
It was established in the 1890s. The company is committed to bringing happiness to customers and employees with its management focusing on the happiness of people. Based on respect for the shared value that "the company work diligently in the youths and live fruitful lives in old age." it serves every customer faithfully by fostering ownership and faith among its members.

Manufacturer usually replies in 13 days

diclofenac sodium

Ampoules, injection 75mg/2mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18707
It was established in the 1980s. The company has continued to attain strong growth and has sprung into a global biotech company with a continuous trade surplus in the global market. The company manufactures more than 150 pharmaceutical products, and approved products are more than 340 products from MFDS (Ministry of Food and Drug Safety). For the quality intensification and maximizing of productive capacity, the company completely equipped its manufacturing structure and facilities for producing pharmaceutical products guaranteed safety and effectiveness with stability.

Manufacturer usually replies in 30 days

diclofenac sodium

Injection 75 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #21503
The company has grown and evolved through research and development, production, and distribution of high-quality health care products, even if it is a short period since the 1980s. It engages in the manufacture, wholesale, export, import, and sale of pharmaceuticals in East Asia and internationally. They have various product groups such as injectable solutions, tablets, capsules, aerosols, and patches.

Manufacturer usually replies in 15 days

diclofenac sodium

Tablets 25 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18707
It was established in the 1980s. The company has continued to attain strong growth and has sprung into a global biotech company with a continuous trade surplus in the global market. The company manufactures more than 150 pharmaceutical products, and approved products are more than 340 products from MFDS (Ministry of Food and Drug Safety). For the quality intensification and maximizing of productive capacity, the company completely equipped its manufacturing structure and facilities for producing pharmaceutical products guaranteed safety and effectiveness with stability.

Manufacturer usually replies in 30 days

diclofenac sodium

Vials, injection Upon request

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18039
The company is established in the 1980s to manufacture medicinal products of good quality, Since the company has been a designated KGMP company in the 1990s, they have been producing more than 80 items including tablets, capsules, injections, and solutions.

Manufacturer usually replies in 7 days

diclofenac sodium

Tablets 25mg, 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #8104
It was established in the late 1950s. It has been making significant efforts to protect the healthy lives of human beings by producing a variety of treatments starting with injection Products. The company operates its business for various customers including business clients, patients, pharmacists, and doctors. They are trying to make their supply chain more effective to provide the necessary medicines faster.

Manufacturer usually replies in 4 days

diclofenac sodium

Eye drops 1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #13108
The company has a corporate mission of protecting precious human life from various forms of diseases. It is focused on improving the health status of the people. The company was established in the 1970s. They have grown in the ethical drug market specializing in IMDs and ophthalmic products.

Manufacturer usually replies in 5 days

Diclofenac Sodium

Diclofenac Sodium, a benzene acetic Acid derivative and nonsteroidal antiinflammatory drug (NSAID), is the sodium salt version of diclofenac. It has analgesic and antipyretic properties and anti-inflammatory activities. Chronic pain due to cancer is commonly treated with diclofenac, particularly if there is inflammation. If necessary, it can be combined with opioids such as codeine and diclofenac. It can be used to treat inflammatory disorders, such as arthritis, polymyositis and rheumatoid, polymyositis and osteoarthritis. Acute migraines can also be treated.

How does Diclofenac Sodium work?

It is a competitive and non-selective inhibitor of cyclooxygenase COX, thereby blocking conversion of arachidonic acids into prostaglandin precursors. This results in an inhibition of prostaglandin formation that is involved in pain, inflammation, and fever. It is commonly used to treat mild to moderate postoperative pain. It can also be used to treat actinic Keratosis and minor strains, sprains and contusions (bruises) that cause acute pain. Diclofenac Sodium was first patented by Ciba-Geigy in 1965. In the United States, it became medically useful in 1988. It can be purchased as a generic drug. It was the 72nd most prescribed medication in America, with over 11 million prescriptions. It can be purchased as either a sodium salt or a potassium salt. Common side effects include nausea, dizziness or headaches. Severe side effects could include heart disease.stroke.kidney problems,and stomach ulceration. The use of the product is not advised during the third trimester in pregnancy. It is advised to stop using NSAIDs for pregnant women after 20 weeks.

Pricing of Diclofenac Sodium

For a 30 tablet supply, diclofenac oral delayed-release tablet sodium 75 mg costs around $14. Voltaren is a brand name for the drug, which is also sold under other names such as Cataflam, Cambiae, Zorvolex, Zipsor Voltaren-XR and Dyloject.

Sourcing Diclofenac Sodium

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Diclofenac Sodium offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturers and this substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Diclofenac Sodium. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Diclofenac Sodium is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Diclofenac Sodium manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.